Buying fatigue hits crude oil

Ole Hansen

Head of Commodity Strategy, Saxo Bank Group
Ole Hansen joined Saxo in 2008 and has been Head of Commodity Strategy since 2010. He focuses on delivering strategies and analyses of the global commodity markets defined by fundamentals, market sentiment and technical developments.

Brent crude oil has been struggling to break above $80/b despite a deteriorating outlook for production in Venezuela and the not yet quantifiable impact of US sanctions on Iran.

Reasons:

A ten-dollar rally since early April could indicate that tighter supply may begin to be priced in.

Opec and Russia may consider easing their production cuts before, or no later than at, their joint meeting on June 23: Argus Media yesterday reported that Saudi Arabia, Russia and the president of Opec are likely to meet this week to discuss a controlled relaxation of the over-compliance caused by the continued slump in Venezuelan production.

The US may struggle to achieve the desired impact on Iranian oil exports given the lack of support from other members of the 2015 nuclear deal

During the past week, instead of triggering additional momentum buying above $80/b, sellers emerged to knock it straight back below. Geopolitical risks are likely to keep a relatively solid floor under the market. But the recent price behaviour could indicate the market is getting ready to consolidate with $77.50/b being the first level of support.

Watch what people do, not what they say: Hedge funds have been net-sellers of crude oil for the past four weeks with the net-long dropping to a five-month low:

Focus today is on the weekly EIA report at 14:30 GMT. Crude stocks are surveyed to have dropped by 2m barrels last week. Gasoline, meanwhile, trades lower as a record fund long reacted negatively to the surprise counter-seasonal rise  reported by the API last night.

Access both platforms from your single Saxo account.

Disclaimer

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice or a personal recommendation and does not take into consideration your objectives, financial situation and needs. Saxo Capital Markets UK Limited will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information. We assume no liability for errors, inaccuracies or omissions contained within these materials.

It is important that you understand that with investments, your capital is at risk. We offer leveraged products which carry risk and can result in losses that exceed deposits. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more here.

Additional Key Information Documents are available in our trading platform.

Saxo Capital Markets UK is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871

Please read our full disclaimer - https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer